Skip to main content

COVID-19: Japanese flu drug ' clearly successful ' in coronavirus treatm...

<iframe width="480" height="270" src="https://www.youtube.com/embed/pRTU7UiFA



Japanese medicine used to treat new flu strains has shown potential to be successful in clinical trials against the coronavirus. The antiviral drug favipiravir, manufactured by a Fujifilm subsidiary, has shown promising results in clinical trials, medical authorities in China claim.


 Separately, China has approved the sale of the first potential drug to treat the infection, Favipiravir, after good clinical trials. A pharmaceutical company in Zhejiang Province has begun manufacturing the drug, and the company says clinical testing will continue. Favipiravir is an existing drug which is widely used to treat flu symptoms. #COVID_19 #Coronavirus #COVID19 #StayHomeStaySafe #CoronaStopKaroNaysg?clip=

Comments

Post a Comment

Popular posts from this blog

❌Coronavirus TIMELINE (Since February 2020)

The novel coronavirus (SARS-Cov-2) began circulating in China in December 2019. The number of confirmed cases and deaths from this pneumonia-like condition are rising. The Latest coverage Updated 25 February 2020 News—Covid-19: surge in cases in Italy and South Korea makes pandemic look more likely A surge in cases in northern Italy on 24 February heightened fears that the emerging infection has passed the tipping point Opinion—Covid-19 highlights the need for greater support for global health systems Countries with weaker health systems must not be left behind in the global emergency response, says Keerti Gedela News— Rules on isolation rooms for suspected covid-19 cases in GP surgeries to be relaxed GPs seeing patients who might have covid-19 can give them a face mask and ask them to sit two metres away from other people in the surgery if no spare room is available, new guidance is expected to say Opinion—The covid-19 outbreak has shown we need strategies to manage panic d...
Post a Comment
Read more

Biolidics Launched Rapid Test Kit For COVID-19

In this video, we take look on Biolidics launched rapid test kits for COVID-19 test in 10 minutes... Not because I have symptoms, but because it was easy and accessible. This is how easy and fast it should be for everyone in the world. Hopefully tests like these will soon be available everywhere . Coronavirus All About Playlist: https://www.youtube.com/playlist?list... . For Further more information about it GIVEN below: Biolidics Singapore-listed medtech company Biolidics recently launched its rapid test kit for COVID-19 and has entered into a manufacturer agreement with a diagnostic kit manufacturer to customize and manufacture the rapid test kits. The first batch of Biolidics’ rapid test kits is expected to be available in April 2020. Biolidics has obtained provisional authorization from Singapore’s Health Science Authority (HSA) for its rapid test kit to be used in Singapore. The medtech company, which focuses on diagnostic cancer solutions, is working closely with Clear ...
Post a Comment
Read more

Coronavirus Treatment

Pakistan has effective drug for COVID-19, Over 300,000 pieces exported to China , an article published by  Economic Daily – China Economic Net (CEN)  on February 21 has got 5.71 million page views on Toutiao.com and 38,000 likes. In nearly 10,000 comments, in addition to a lot of thanks to Pakistani friends for their help, some netizens were interested in the “multinational enterprise” mentioned in the CEN reporter’s article and wanted to know the hero behind the scenes who urgently dispensed the effective drugs at a Bayer subsidiary in Pakistan. On February 20th, after noticing that the official Weibo account of Bayer China said it had made an emergency deployment of chloroquine phosphate tablets in Pakistan at the beginning of this month, CEN reporter quickly contacted to verify the matter. The official Weibo account of Bayer China confirmed the news and said that the batch of medicines was completed in 24 hours. 200,000 of the 300,000 tablets were “sold” to Guangzhou Pharma...
Post a Comment
Read more